|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61M 31/00 | |
| A61F 9/00 |
| (11) | Number of the document | 3265165 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16762267.9 |
| Date of filing the European patent application | 2016-03-04 | |
| (97) | Date of publication of the European application | 2018-01-10 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/021081 |
| Date | 2016-03-04 |
| (87) | Number | WO 2016/144832 |
| Date | 2016-09-15 |
| (30) | Number | Date | Country code |
| 201562129737 P | 2015-03-06 | US | |
| 201562263373 P | 2015-12-04 | US | |
| 201562263396 P | 2015-12-04 | US |
| (72) |
NAVRATIL, Tomas, US
DELGADO, Jessie, US
HUNTER, Michael, US
|
| (73) |
Aerie Pharmaceuticals, Inc.,
2030 Main Street, Suite 1500, Irvine CA 92614,
US
|
| (54) | IMPLANT APPLICATORS |
| IMPLANT APPLICATORS |